My research concentrates on innovative cost-effective and cost-beneficial solutions in public and private sector to improve health among the poorest. I am an expert in health information systems analysis, with a focus on cost-benefit and cost-effectiveness analyses of health interventions. With more than 35 years of working the public health sector, I have extensive experience studying testing and evaluating health interventions in the US and in more than 20 poor and middle income countries in Africa, Asia, and Latin America. I was the founding director of the highly successful USAID Data for Decision Making Project while on the faculty at Harvard University and led that multimillion dollar, multi-institutional, multi-country cooperative agreement on health system reform for several years.
I have broad experience with many international agencies as consultant or expert advisor. As a consultant, I have conducted an analysis of the market feasibility, costs, and cost-effectiveness of the new method of fortification of rice with multivitamins in Columbia and India and a cost effectiveness of improvements in health information systems to enhance information based decision-making in poor countries. In addition to modeling the costs and cost-effectiveness of priority interventions for maternal health, I have estimated market size for improved diagnostics for pneumonia and chlamydia in Tanzania and for vaginal technologies to decrease STD. My team evaluated an innovative computer video-assisted method for improving health in rural Uttar Pradesh India that video connects patients and rural health practitioners with physicians in Delhi. I designed a cost-effectiveness comparison of social franchising and social marketing of antibiotic treatment for childhood pneumonia in Myanmar. For the Seguro Popular, the Mexican insurance scheme for the poor, I have assessed priorities for improving neonatal mortality.
My ‘Citation Classic’ publications are used globally for teaching health care in developing countries. I have a keen interest in the widespread market penetration of evidence-based health interventions. At UC Berkeley, I have taught the Global Public Health core course and a course on cost-effectiveness analysis.